Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients

被引:16
|
作者
Saleki, Kiarash [1 ,2 ,3 ,4 ]
Shirzad, Moein [1 ,2 ,4 ]
Javanian, Mostafa [5 ]
Mohammadkhani, Sheyda [2 ]
Alijani, Mohammad Hossein [2 ]
Miri, Niloufarsadat [1 ]
Oladnabi, Morteza [6 ]
Azadmehr, Abbas [1 ,4 ,7 ]
机构
[1] Babol Univ Med Sci, Hlth Res Inst, Cellular & Mol Biol Res Ctr, Babol, Iran
[2] Babol Univ Med Sci, Student Res Comm, Babol, Iran
[3] Babol Univ Med Sci, USERN Off, Babol, Iran
[4] Natl Elite Fdn, Mazandaran Prov Branch, Mazandaran, Iran
[5] Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol, Iran
[6] Golestan Univ Med Sci, Ischem Disorders Res Ctr, Gorgan, Iran
[7] Babol Univ Med Sci, Immunol Dept, Babol, Iran
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
COVID-19; hyperinflammation; Fas; viral Immunology; immunoinformatics; AA FORCE-FIELD; EXPRESSION; APOPTOSIS; INJURY; ACTIVATION; VIRUS; GENE;
D O I
10.3389/fimmu.2022.947401
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Finding cytokine storm initiator factors associated with uncontrolled inflammatory immune response is necessary in COVID-19 patients. The aim was the identification of Fas/Fas Ligand (FasL) role in lung involvement and mortality of COVID-19 patients. In this case-control study, mild (outpatient), moderate (hospitalized), and severe (ICU) COVID-19 patients and healthy subjects were investigated. RNA isolated from PBMCs for cDNA synthesis and expression of mFas/mFasL mRNA was evaluated by RT-PCR. Serum sFas/sFasL protein by ELISA and severity of lung involvement by CT-scan were evaluated. Also, we docked Fas and FasL via Bioinformatics software (in silico) to predict the best-fit Fas/FasL complex and performed molecular dynamics simulation (MDS) in hyponatremia and fever (COVID-19 patients), and healthy conditions. mFasL expression was increased in moderate and severe COVID-19 patients compared to the control group. Moreover, mFas expression showed an inverse correlation with myalgia symptom in COVID-19 patients. Elevation of sFasL protein in serum was associated with reduced lung injury and mortality. Bioinformatics analysis confirmed that blood profile alterations of COVID-19 patients, such as fever and hyponatremia could affect Fas/FasL complex interactions. Our translational findings showed that decreased sFasL is associated with lung involvement; severity and mortality in COVID-19 patients. We think that sFasL is a mediator of neutrophilia and lymphopenia in COVID-19. However, additional investigation is suggested. This is the first report describing that the serum sFasL protein is a severity and mortality prognostic marker for the clinical management of COVID-19 patients.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Serum decorin and biglycan levels as predictive biomarkers for lung fibrosis severity and mortality risk in COVID-19 patients
    Ahmad, Shaaf
    Maqsood, Kaleem
    Liaqat, Farwa
    Roohi, Nabila
    FRONTIERS IN MEDICINE, 2025, 11
  • [22] Factors related to mortality of patients with COVID-19 who are admitted to the ICU: Prognostic mortality factors of COVID-19 patients
    alvarez-Macias, Alejandro
    ubeda-Iglesias, Alejandro
    Macias-Seda, Juana
    Gomez-Salgado, Juan
    MEDICINE, 2024, 103 (21) : E38266
  • [23] Prognostic value of serum amyloid A in patients with COVID-19
    Li Cheng
    Jian-Zhong Yang
    Wen-Hui Bai
    Zhuan-Yun Li
    Li-Fang Sun
    Juan-Juan Yan
    Chen-Liang Zhou
    Bao-Peng Tang
    Infection, 2020, 48 : 715 - 722
  • [24] Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
    Ren, Huihui
    Yang, Yan
    Wang, Fen
    Yan, Yongli
    Shi, Xiaoli
    Dong, Kun
    Yu, Xuefeng
    Zhang, Shujun
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [25] Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19
    Tomaskova, Veronika
    Mytnikova, Alexandra
    Kohoutkova, Marcela Hortova
    Mrkva, Ondrej
    Skotakova, Monika
    Sitina, Michal
    Helanova, Katerina
    Fric, Jan
    Parenica, Jiri
    Sramek, Vladimir
    Helan, Martin
    FRONTIERS IN MEDICINE, 2022, 9
  • [26] Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
    Huihui Ren
    Yan Yang
    Fen Wang
    Yongli Yan
    Xiaoli Shi
    Kun Dong
    Xuefeng Yu
    Shujun Zhang
    Cardiovascular Diabetology, 19
  • [27] Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker in COVID-19 patients: a systematic review
    Lobato-martinez, E.
    Sanchez-martinez, R.
    Balsa, E. de-miguel
    Ramos-rincon, J. -m.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2024, 28 (02) : 852 - 860
  • [28] Serum Cystatin C Levels as a Predictor of Severity and Mortality Among Patients With COVID-19 Infection
    Prasad, Kavya
    Kulkarni, Ashwin
    Navikala, K.
    Gowda, Vanitha
    Shaikh, Mohammed Aslam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [29] Prognostic value of serum amyloid A in patients with COVID-19
    Cheng, Li
    Yang, Jian-Zhong
    Bai, Wen-Hui
    Li, Zhuan-Yun
    Sun, Li-Fang
    Yan, Juan-Juan
    Zhou, Chen-Liang
    Tang, Bao-Peng
    INFECTION, 2020, 48 (05) : 715 - 722
  • [30] COVID-19 Mortality and Severity in Cancer Patients and Cancer Survivors
    Park, Jae -Min
    Koo, Hye Yeon
    Lee, Jae-ryun
    Lee, Hyejin
    Lee, Jin Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (02)